{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerosis%2C+Coronary&page=21", "query": { "condition": "Atherosclerosis, Coronary", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 2158, "total_pages": 216, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerosis%2C+Coronary&page=22&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerosis%2C+Coronary&page=20&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T16:03:30.344Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00269048", "title": "SB-480848 In Subjects With Coronary Heart Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "SB-480848", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 969, "start_date": "2005-11", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2016-08-08", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Northport, Alabama • Phoenix, Arizona + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Spring Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00269048" }, { "nct_id": "NCT06114615", "title": "Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "LiveCare", "type": "DEVICE" }, { "name": "Text Messages", "type": "BEHAVIORAL" }, { "name": "Conventional Care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2024-01-01", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06114615" }, { "nct_id": "NCT00000620", "title": "Action to Control Cardiovascular Risk in Diabetes (ACCORD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerosis", "Cardiovascular Diseases", "Hypercholesterolemia", "Hypertension", "Diabetes Mellitus, Type 2", "Diabetes Mellitus", "Coronary Disease" ], "interventions": [ { "name": "Anti-hyperglycemic Agents", "type": "DRUG" }, { "name": "Anti-hypertensive Agents", "type": "DRUG" }, { "name": "Blinded fenofibrate or placebo plus simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "40 Years to 79 Years" }, "enrollment_count": 10251, "start_date": "1999-09", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2016-11-22", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 6, "location_summary": "Minneapolis, Minnesota • New York, New York • Winston-Salem, North Carolina + 3 more", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000620" }, { "nct_id": "NCT01312935", "title": "Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Percutaneous Coronary Intervention", "Coronary Artery Disease (CAD)", "Angioplasty" ], "interventions": [ { "name": "PMX-60056", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PolyMedix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2011-04", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2012-05-17", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 3, "location_summary": "South Bend, Indiana • Detroit, Michigan • Rapid City, South Dakota", "locations": [ { "city": "South Bend", "state": "Indiana" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Rapid City", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01312935" }, { "nct_id": "NCT01342029", "title": "Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Microvascular Coronary Dysfunction (MCD)" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 142, "start_date": "2011-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 2, "location_summary": "Los Angeles, California • Gainesville, Florida", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01342029" }, { "nct_id": "NCT03404180", "title": "Peripheral Nerve Blocks for Above-the-knee Amputations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Peripheral Vascular Diseases", "Hyperglycaemia (Diabetic)", "Hypertension", "Coronary Artery Disease", "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Peripheral nerve block", "type": "PROCEDURE" }, { "name": "Intravenous Sedatives", "type": "DRUG" }, { "name": "Lateral femoral cutaneous nerve blocks", "type": "PROCEDURE" }, { "name": "Obturator nerve blocks", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2018-02-09", "completion_date": "2024-12-18", "has_results": true, "last_update_posted_date": "2026-01-08", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03404180" }, { "nct_id": "NCT00655070", "title": "Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Myocardial Ischemia" ], "interventions": [ { "name": "Timi3 Transthoracic ultrasound", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2008-04", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2012-04-04", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00655070" }, { "nct_id": "NCT01732341", "title": "Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myocardial Infarction" ], "interventions": [ { "name": "STENTYS self-apposing stent", "type": "DEVICE" }, { "name": "VISION balloon-expandable stent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Stentys", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 318, "start_date": "2013-05", "completion_date": "2017-03", "has_results": false, "last_update_posted_date": "2017-04-20", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 2, "location_summary": "La Jolla, California • New York, New York", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01732341" }, { "nct_id": "NCT00069654", "title": "Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Arteriosclerosis" ], "interventions": [ { "name": "Forearm blood flow study", "type": "PROCEDURE" }, { "name": "Brachial artery reactivity study", "type": "PROCEDURE" }, { "name": "Treadmill exercise test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 42, "start_date": "2003-09-25", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00069654" }, { "nct_id": "NCT03789552", "title": "Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Stable Angina Pectoris" ], "interventions": [ { "name": "T89 capsule", "type": "DRUG" }, { "name": "Placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tasly Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 765, "start_date": "2019-08-01", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-10-14T16:03:30.344Z", "location_count": 1, "location_summary": "Naples, Florida", "locations": [ { "city": "Naples", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03789552" } ] }